Genmab A/S (GMAB) Ownership

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$26.55
Day's range
$27.32

Genmab Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
PARADIGM BIOCAPITAL ADVISORS LP 08/14/2026 13.13 M $360.77 M   64.83% 2.14%
ORBIS ALLAN GRAY LTD 08/14/2026 11.37 M $312.28 M   -12.05% 1.85%
ALLIANCEBERNSTEIN L.P. 08/14/2026 8.64 M $231.94 M   -9.55% 1.41%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 08/14/2026 6.87 M $188.58 M   178.84% 1.12%
DEEP TRACK CAPITAL, LP 08/14/2026 5.65 M $155.21 M   54.23% 0.92%
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP 08/13/2026 4.98 M $136.67 M   0.00% 0.81%
BLACKROCK, INC. 08/07/2026 4.67 M $128.32 M   2.97% 0.76%
SOFINNOVA INVESTMENTS, INC. 08/14/2026 4.05 M $111.12 M   437.74% 0.66%
RENAISSANCE TECHNOLOGIES LLC 08/13/2026 3.52 M $96.64 M   -20.31% 0.57%
TWO SIGMA INVESTMENTS, LP 08/14/2026 3.51 M $96.33 M   49.90% 0.57%
HARDING LOEVNER LP 08/14/2026 3.09 M $86.90 M   -4.50% 0.50%
DEEP TRACK CAPITAL, LP 08/14/2026 3.00 M $82.41 M   100.00% 0.49%
FIRST TRUST ADVISORS LP 08/11/2026 2.76 M $75.72 M   11.99% 0.45%
CITADEL ADVISORS LLC 08/14/2026 2.48 M $68.02 M   100.00% 0.40%
QUBE RESEARCH & TECHNOLOGIES LTD 08/14/2026 1.69 M $46.40 M   149.40% 0.28%
MORGAN STANLEY 08/13/2026 1.63 M $44.78 M   -25.38% 0.27%
FEDERATED HERMES, INC. 08/12/2026 1.45 M $39.81 M   15.80% 0.24%
GOLDMAN SACHS GROUP INC 08/14/2026 1.28 M $35.14 M   37.37% 0.21%
FRANKLIN RESOURCES INC 08/13/2026 1.20 M $33.04 M   0.82% 0.20%
PICTET ASSET MANAGEMENT HOLDING SA 07/30/2026 1.07 M $29.28 M   -1.07% 0.17%
UBS GROUP AG 08/13/2026 961.05 K $26.40 M   222.36% 0.16%
PERPETUAL LTD 07/15/2026 919.05 K $25.25 M   21.17% 0.15%
NORTHERN TRUST CORP 08/13/2026 916.60 K $25.18 M   -3.57% 0.15%
MILLENNIUM MANAGEMENT LLC 08/14/2026 910.60 K $25.01 M   14.93% 0.15%
RUSSELL INVESTMENTS GROUP, LTD. 08/06/2026 883.43 K $24.27 M   10.84% 0.14%
ENVESTNET ASSET MANAGEMENT INC 08/03/2026 829.69 K $22.79 M   -3.78% 0.14%
MARSHALL WACE, LLP 08/13/2026 829.66 K $22.79 M   5,431.06% 0.14%
ALYESKA INVESTMENT GROUP, L.P. 08/14/2026 804.37 K $22.10 M   24.62% 0.13%
FMR LLC 08/13/2026 764.69 K $21.01 M   -24.42% 0.12%
JPMORGAN CHASE & CO 08/12/2026 744.82 K $19.38 M   234.59% 0.12%
CAPTION MANAGEMENT, LLC 08/14/2026 698.00 K $19.17 M   100.00% 0.11%
AMERICAN CENTURY COMPANIES INC 08/12/2026 599.95 K $16.48 M   11.32% 0.10%
CIBC WORLD MARKET INC. 08/13/2026 514.76 K $14.14 M   5.43% 0.08%
OPPENHEIMER ASSET MANAGEMENT INC. 08/03/2026 447.43 K $12.29 M   -2.20% 0.07%
SUPERSTRING CAPITAL MANAGEMENT LP 08/14/2026 430.60 K $11.83 M   118.90% 0.07%
MOORE CAPITAL MANAGEMENT, LP 08/14/2026 420.49 K $11.55 M   98.62% 0.07%
DIXON MITCHELL INVESTMENT COUNSEL INC. 08/13/2026 416.00 K $11.43 M   100.00% 0.07%
QUANTINNO CAPITAL MANAGEMENT LP 08/13/2026 333.39 K $9.16 M   18.01% 0.05%
HUDSON BAY CAPITAL MANAGEMENT LP 08/14/2026 330.00 K $9.07 M   6.45% 0.05%
SUMMITTX CAPITAL, L.P. 08/14/2026 318.41 K $8.75 M   277.47% 0.05%
CITADEL ADVISORS LLC 08/14/2026 312.30 K $8.58 M   81.04% 0.05%
WELLS FARGO & COMPANY/MN 08/14/2026 303.64 K $8.34 M   -4.99% 0.05%
BANK OF AMERICA CORP /DE/ 08/14/2026 259.25 K $7.12 M   7.34% 0.04%
EAGLE GLOBAL ADVISORS LLC 07/30/2026 244.73 K $6.72 M   0.07% 0.04%
ASSETMARK, INC 07/30/2026 238.80 K $6.56 M   6.54% 0.04%
JANE STREET GROUP, LLC 08/14/2026 237.30 K $6.52 M   125.79% 0.04%
BNP PARIBAS ARBITRAGE, SNC 08/13/2026 227.99 K $6.26 M   0.18% 0.04%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 08/14/2026 221.40 K $6.08 M   107.30% 0.04%
CAPTION MANAGEMENT, LLC 08/14/2026 199.77 K $5.49 M   100.00% 0.03%
FOLKETRYGDFONDET 08/13/2026 165.08 K $4.53 M   2.68% 0.03%

Genmab institutional Ownership - FAQ's

During the previous two years, 391 institutional investors and hedge funds held shares of Genmab. The most heavily invested institutionals were:

Paradigm Biocapital Advisors LP: 13.13 M

Orbis Allan Gray Ltd: 11.37 M

ALLIANCEBERNSTEIN L.P.: 8.64 M

DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C): 6.87 M

Deep Track Capital, LP: 5.65 M

ARROWSTREET CAPITAL, LIMITED PARTNERSHIP: 4.98 M

16.69% of Genmab stock is owned by institutional investors.

Institutional investors have bought a total of 115.19 M shares in the last 24 months. This purchase volume represents approximately $3.14 B in transactions.